Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Euhus

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Annals of Surgical Oncology|December 10, 2016
Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) MastectomyKelly K Hunt, David M Euhus, Judy C Boughey, et al.
Cancer Research|January 4, 2008
RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriersBoning Gao, Xian-Jin Xie, Chunxian Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Diabetes, metformin, and breast cancer in postmenopausal womenRowan T Chlebowski, Anne McTiernan, Jean Wactawski-Wende, et al.
Journal of the National Cancer Institute|June 6, 2002
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRODavid M Euhus, Kristin C Smith, Linda Robinson, et al.
Cancer|March 20, 2002
Ductal lavage and the clinical management of women at high risk for breast carcinoma: a commentaryJoyce A O'Shaughnessy, Britt Marie Ljung, William C Dooley, et al.
Molecular Cancer Therapeutics|July 26, 2013
Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancersErik A Bey, Kathryn E Reinicke, Melissa C Srougi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Characterization of BRCA1 and BRCA2 mutations in a large United States sampleSining Chen, Edwin S Iversen, Tara Friebel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker StudyKala Visvanathan, MaryJo S Fackler, Zhe Zhang, et al.
Plos Medicine|December 30, 2006
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignanciesDavid S Shames, Luc Girard, Boning Gao, et al.
Annals of Internal Medicine|October 3, 2007
Validity of models for predicting BRCA1 and BRCA2 mutationsGiovanni Parmigiani, Sining Chen, Edwin S Iversen, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Annals of Surgical Oncology|December 10, 2016
Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) MastectomyKelly K Hunt, David M Euhus, Judy C Boughey, et al.
Cancer Research|January 4, 2008
RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriersBoning Gao, Xian-Jin Xie, Chunxian Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Diabetes, metformin, and breast cancer in postmenopausal womenRowan T Chlebowski, Anne McTiernan, Jean Wactawski-Wende, et al.
Journal of the National Cancer Institute|June 6, 2002
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRODavid M Euhus, Kristin C Smith, Linda Robinson, et al.
Cancer|March 20, 2002
Ductal lavage and the clinical management of women at high risk for breast carcinoma: a commentaryJoyce A O'Shaughnessy, Britt Marie Ljung, William C Dooley, et al.
Molecular Cancer Therapeutics|July 26, 2013
Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancersErik A Bey, Kathryn E Reinicke, Melissa C Srougi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Characterization of BRCA1 and BRCA2 mutations in a large United States sampleSining Chen, Edwin S Iversen, Tara Friebel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker StudyKala Visvanathan, MaryJo S Fackler, Zhe Zhang, et al.
Plos Medicine|December 30, 2006
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignanciesDavid S Shames, Luc Girard, Boning Gao, et al.
Annals of Internal Medicine|October 3, 2007
Validity of models for predicting BRCA1 and BRCA2 mutationsGiovanni Parmigiani, Sining Chen, Edwin S Iversen, et al.
Pageof 7